Bookbuilding IPO | ₹[.] Cr | Listing at BSE SME |
Himalaya Nutravedics India Ltd. has filed a Draft Red Herring Prospectus (DRHP) with the exchange on March 28, 2026 to raise funds through Initial Public Offer (IPO).
Himalaya Nutravedics India Ltd. IPO is a Book Build Issue consisting solely of fresh issue of upto 0.25 crore equity shares.
The equity shares are proposed to be listed on the BSE SME. Nirbhay Capital Services Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Himalaya Nutravedics IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 25,00,000 shares (agg. up to ₹[.] Cr) |
| Fresh Issue | 25,00,000 shares (agg. up to ₹[.] Cr) |
| Share Holding Pre Issue | 63,06,720 shares |
| Share Holding Post Issue | 88,06,720 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Sat, Mar 28, 2026 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Offer |
| Retail Shares Offered | Not less than 35% of the Net Offer |
| NII Shares Offered | Not less than 15% of the Net Offer |
Himalaya Nutravedics India Ltd is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations in India. In addition to its own branded products, the company also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies.
It offers a diversified product portfolio that includes classical Ayurvedic formulations based on traditional texts, proprietary Ayurvedic products, and nutraceutical supplements. These are available in multiple dosage forms such as soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, and medicated oils.
The company operates through a hybrid business model, balancing its own-brand formulations with contract manufacturing services. It has an integrated in-house manufacturing facility located in Hyderabad, Telangana. As of September 2025, its products are distributed across multiple states in India, with a strong revenue presence in Telangana, Andhra Pradesh, Kerala, Gujarat, and Uttar Pradesh.
Its product portfolio spans a wide range of wellness and therapeutic segments, including digestive health, immunity, metabolic health, musculoskeletal and joint care, reproductive health, respiratory wellness, pain management, and general well-being. These formulations are designed to support general wellness, nutritional supplementation, and lifestyle-related health needs, in line with applicable regulatory standards.
Competitive Strengths:
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 17.88 | 10.82 | 6.09 | 3.24 |
| Total Income | 20.19 | 21.00 | 14.43 | 2.05 |
| Profit After Tax | 3.45 | 2.23 | 0.43 | 0.10 |
| EBITDA | 3.75 | 2.99 | 0.94 | 0.23 |
| NET Worth | 10.20 | 6.75 | 1.34 | 0.91 |
| Reserves and Surplus | 6.21 | 2.76 | 0.53 | 0.10 |
| Total Borrowing | 4.82 | 1.76 | 3.24 | 1.32 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding Working Capital Requirements | 13.75 |
| 2 | Business Development and Digital Marketing Activities | 5.00 |
| 3 | General Corporate Purposes | |
| Total | 18.75 |
| KPI | Sep 30, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 40.70% | 55.02% |
| ROCE | 23.98% | 30.18% |
| Debt/Equity | 0.47 | 0.26 |
| RoNW | 33.84% | 33.08% |
| PAT Margin | 17.11% | 10.63% |
| EBITDA Margin | 18.61% | 14.24% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 95.14% |
Lead Manager Reports
Himalaya Nutravedics IPO is a SME IPO of 25,00,000 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The Himalaya Nutravedics IPO open and close dates are not available as of now.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Himalaya Nutravedics IPO using UPI as a payment gateway. Zerodha customers can apply in Himalaya Nutravedics IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Himalaya Nutravedics IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Himalaya Nutravedics IPO dates are not announced. Please check back again after some time.
Himalaya Nutravedics IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Himalaya Nutravedics IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Himalaya Nutravedics IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Himalaya Nutravedics IPO allotment status.
The Himalaya Nutravedics IPO listing date is not yet announced. The tentative date of listing is .
